From trying to create new cartilage in the laboratory to clinical trials for patients with brain injuries, scientists and physicians at The University of Texas Health Science Center at Houston (UTHealth) are leading the way in stem cell research.
In partnership with Memorial Hermann-Texas Medical Center, UTHealth was the first in the country to intravenously inject a stroke patient’s own stem cells in a trial funded by the National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health. Learn how researchers continue to push the boundaries of this promising field.
Biostage Announces the Use of Its Esophageal Implant Product Candidate in a Patient
UTHealth was cited in a news release on a bioengineered organ implant by Biostages Inc. that has been picked up by 85 media outlets including The Street.
Continue reading »
UTHealth stroke researchers on the leading edge of stem cell science
The effects of multipotent adult progenitor stem cells on stroke recovery were the focus of two recently published papers that include researchers at the Institute for Stroke and Cerebrovascular Disease at The University of Texas Health Science Center at Houston (UTHealth).Continue reading »
UTHealth research shows how cancer cells hijack the lymphatic system
A molecular stress test has revealed how cancer cells use the lymphatic system to spread throughout the body, report scientists from McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth) in the journal Nature Communications.Continue reading »